Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $21,816 - $24,839
229 Added 5.84%
4,147 $401,000
Q3 2023

Nov 02, 2023

BUY
$94.73 - $105.13 $21,314 - $23,654
225 Added 6.09%
3,918 $399,000
Q1 2023

May 05, 2023

SELL
$80.03 - $92.81 $80,030 - $92,810
-1,000 Reduced 21.31%
3,693 $339,000
Q4 2022

Feb 14, 2023

SELL
$75.55 - $92.52 $35,281 - $43,206
-467 Reduced 9.05%
4,693 $425,000
Q3 2022

Nov 02, 2022

SELL
$74.61 - $87.26 $7,386 - $8,638
-99 Reduced 1.88%
5,160 $392,000
Q2 2022

Jul 27, 2022

SELL
$80.52 - $93.75 $7,568 - $8,812
-94 Reduced 1.76%
5,259 $445,000
Q1 2022

May 03, 2022

SELL
$80.11 - $90.62 $17,624 - $19,936
-220 Reduced 3.95%
5,353 $470,000
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $51,884 - $57,372
651 Added 13.23%
5,573 $487,000
Q2 2021

Aug 12, 2021

SELL
$85.24 - $94.15 $1,278 - $1,412
-15 Reduced 0.3%
4,922 $449,000
Q1 2021

May 14, 2021

SELL
$83.5 - $98.47 $15,447 - $18,216
-185 Reduced 3.61%
4,937 $422,000
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $11,710 - $14,164
-150 Reduced 2.85%
5,122 $484,000
Q3 2020

Nov 13, 2020

BUY
$82.14 - $91.0 $16,428 - $18,200
200 Added 3.94%
5,272 $458,000
Q1 2020

May 08, 2020

SELL
$70.67 - $99.01 $2,826 - $3,960
-40 Reduced 0.78%
5,072 $418,000
Q2 2019

Aug 09, 2019

BUY
$75.4 - $92.8 $160,225 - $197,200
2,125 Added 71.14%
5,112 $467,000
Q1 2019

May 13, 2019

BUY
$75.32 - $86.15 $46,397 - $53,068
616 Added 25.98%
2,987 $287,000
Q3 2018

Nov 13, 2018

BUY
$66.94 - $77.43 $158,714 - $183,586
2,371 New
2,371 $204,000
Q2 2018

Aug 06, 2018

SELL
$64.91 - $73.36 $192,847 - $217,952
-2,971 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$70.39 - $84.15 $14,993 - $17,923
-213 Reduced 6.69%
2,971 $240,000
Q4 2017

Feb 15, 2018

BUY
$72.33 - $77.64 $230,298 - $247,205
3,184
3,184 $267,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Hoyle Cohen, LLC Portfolio

Follow Hoyle Cohen, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoyle Cohen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hoyle Cohen, LLC with notifications on news.